59.18
전일 마감가:
$59.92
열려 있는:
$59.6
하루 거래량:
140.57K
Relative Volume:
0.06
시가총액:
$8.98B
수익:
$3.46B
순이익/손실:
$-9.40M
주가수익비율:
-246.15
EPS:
-0.2404
순현금흐름:
$51.30M
1주 성능:
+2.35%
1개월 성능:
-2.28%
6개월 성능:
+54.27%
1년 성능:
+74.72%
Bruker Corp Stock (BRKR) Company Profile
명칭
Bruker Corp
전화
978663-3660
주소
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
BRKR
Bruker Corp
|
58.92 | 8.94B | 3.46B | -9.40M | 51.30M | -0.2404 |
|
ABT
Abbott Laboratories
|
114.41 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
329.54 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
92.12 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
49.42 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.35 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-10 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | 개시 | Goldman | Sell |
| 2025-11-20 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-19 | 개시 | Guggenheim | Buy |
| 2024-12-10 | 개시 | UBS | Neutral |
| 2024-12-05 | 업그레이드 | Goldman | Sell → Neutral |
| 2024-10-15 | 개시 | Barclays | Overweight |
| 2024-09-30 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2022-10-21 | 개시 | UBS | Buy |
| 2022-08-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2021-02-05 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | 개시 | Goldman | Sell |
| 2020-11-16 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | 다운그레이드 | Cleveland Research | Buy → Neutral |
| 2020-04-02 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | 다운그레이드 | Needham | Strong Buy → Hold |
| 2020-03-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | 업그레이드 | Goldman | Sell → Neutral |
| 2019-06-24 | 재확인 | Needham | Strong Buy |
| 2019-06-21 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-30 | 개시 | Wolfe Research | Peer Perform |
| 2019-05-06 | 재확인 | Needham | Strong Buy |
| 2019-05-03 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | 업그레이드 | UBS | Sell → Neutral |
| 2019-04-12 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-02-12 | 재확인 | BTIG Research | Buy |
| 2019-01-03 | 개시 | Needham | Strong Buy |
모두보기
Bruker Corp 주식(BRKR)의 최신 뉴스
Ceredex Value Advisors LLC Acquires Shares of 213,450 Bruker Corporation $BRKR - MarketBeat
Advisors Capital Management LLC Purchases Shares of 81,937 Bruker Corporation $BRKR - MarketBeat
Bruker Corporation (NASDAQ:BRKR) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Bruker BeST CEO Burkhard Prause Receives RSUs and Stock Options in August 2026 - Kalkine Media
Bruker Corp's Chief Accounting Officer Thomas Bures Granted 4,035 RSUs - Kalkine Media
Bruker Corp's BMID President Wolfgang Pusch Reports RSU and Option Grants Plus Stock Sale - Kalkine Media
Bruker (NASDAQ: BRKR) insider logs latest stock trades - Stock Titan
Bruker (BRKR) insider pairs 3,473-share sale with new equity grants - Stock Titan
Bruker (NASDAQ: BRKR) grants CFO multi-year equity package - Stock Titan
Bruker (NASDAQ: BRKR) EVP Munch sells 2,000 shares after fresh stock grants - Stock Titan
Bruker (NASDAQ: BRKR) holder to sell 3,473 shares - Stock Titan
Old West Investment Management LLC Acquires Shares of 667,103 Bruker Corporation $BRKR - MarketBeat
44,895 Shares in Bruker Corporation $BRKR Purchased by Walleye Trading LLC - MarketBeat
Bruker Corporation $BRKR Shares Sold by Bank of America Corp DE - MarketBeat
Bruker declares $0.05 quarterly dividend for common shareholders By Investing.com - Investing.com Australia
Bruker declares $0.05 quarterly dividend for common shareholders - Investing.com
BRKR insider to sell 2,000 shares after recent monthly stock sales - Stock Titan
Bruker (BRKR) Is Up 13.0% After Cutting 2026 Outlook And Expanding AI Lab Tie-Up With Atinary - simplywall.st
Bruker Corporation (BRKR) sets $0.05 per-share cash dividend with October 2026 payout - Stock Titan
Bruker Corporation Declares Quarterly Cash Dividend, Payable on October 7, 2026 - marketscreener.com
Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories - AOL.com
Bruker Corp (BRKR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bruker Corp Executive Mark Munch Reports Share Withholding to Cover RSU Tax Obligations - Kalkine Media
Bruker CFO Gerald N. Herman Reports Share Withholding on RSU Vesting Transaction - Kalkine Media
Bruker Corp (BRKR) EVP Mark Munch reports 1,619-share tax-withholding event - Stock Titan
BRKR|Bruker Corp|Price:59.250|Chg%:+2.230 - TradingKey
The 5 Most Interesting Analyst Questions From Bruker’s Q2 Earnings Call - Yahoo Finance
Bruker Corporation (BRKR) Stock Forecasts - Yahoo Finance
Bruker Corp (BRKR) EVP Mark Munch reports 3,477-share RSU tax withholding - Stock Titan
Bruker Expands Atinary Collaboration, Makes Minority Investment in AI R&D Firm - marketscreener.com
Bruker expands collaboration with Atinary, makes investment By Investing.com - Investing.com
MA-BRUKER - Caledonian Record
Bruker Corporation and Atinary Technologies Inc. Announce Strategic Collaboration to Advance Self-Driving Laboratories - marketscreener.com
Q4 2025 Bruker Corp Earnings Call Transcript - GuruFocus
Bruker Corp (BRKR) Shares Surge 5.5% -- What GF Score of 77 Tells Investors - GuruFocus
Bruker takes majority stake in organ-on-a-chip firm MIMETAS - Investing.com South Africa
MIMETAS Develops Organ-on-a-Chip Models for Drug Testing - Stock Titan
Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development - Yahoo Finance
Bruker Acquires Majority Stake in Mimetas to Expand Disease Biology Research - marketscreener.com
BRKRP | Bruker Corporation 6.375% Mandatory Insider Trading - Quiver Quantitative
California State Teachers Retirement System Boosts Stock Position in Bruker Corporation $BRKR - MarketBeat
A Look at Bruker Corp (BRKR) After 4.2% Gain -- GF Value $60.43 vs Price $53.41 - GuruFocus
Bruker Corp (BRKR) Stock News Today - TradingKey
Bruker Corp (BRKR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bruker Corp (BRKR) Stock Analysis & Forecast - TradingKey
Amundi Increases Stock Position in Bruker Corporation $BRKR - MarketBeat
Bruker Corp (BRKR): FMR LLC and Abigail Johnson report 15% ownership - Stock Titan
Bruker Corp (BRKR) Stock Up 4.3% and Still Undervalued -- GF Sco - GuruFocus
Is Bruker (BRKR) Fairly Valued After Its 52 Week High? - Yahoo Finance
Bruker Corp Q2 2026: Revenue $838.5M, EPS $(0.41) — 10-Q Summary - TradingView
Bruker Corporation (NASDAQ: BRKR) hit by $134.9M goodwill charge in Q2 - Stock Titan
Bruker Corp (BRKR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):